Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treating myasthenia gravis and preparation method thereof

A technology for myasthenia gravis and medicament, which can be used in pharmaceutical formulations, medical preparations containing active ingredients, and drug combinations, etc., can solve the problems of large trauma, inability to cure the operation, and high price of thymus removal.

Inactive Publication Date: 2014-12-03
王霞
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Plasma exchange therapy is effective, but the price is very expensive, and most patients cannot accept it
Surgical removal of thymus is traumatic, and surgery cannot cure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Embodiment 1: A kind of medicament for treating myasthenia gravis, raw material composition and parts by weight are: 310 parts of Radix Acanthopanax, 230 parts of Achyranthes bidentata, 260 parts of Pentacles, 240 parts of Diaodia, 180 parts of Caddis , 150 parts of Zijinniu, 200 parts of Dawanhua, 260 parts of black sesame, 350 parts of dried rehmannia glutinosa, 150 parts of Geli, 300 parts of milk ginseng, 50 parts of astragalus, 80 parts of cornus, 60 parts of yam, 50 parts Cuscuta, 40 parts of Chuanxiong, 30 parts of licorice, 35 parts of Ganoderma lucidum, 40 parts of Epimedium, 50 parts of tangerine peel, 28 parts of Cistanche, 65 parts of Polygonum multiflorum, 40 parts of Cornus officinalis, 60 parts of woody fragrance.

[0055] The preparation method is as follows:

[0056] (1) Prepare materials, prepare each component according to the formula;

[0057] (2) Clean the prepared raw materials with flowing tap water respectively, dry them, and set them aside;

...

Embodiment 2

[0064] Embodiment 2: A kind of medicament for treating myasthenia gravis, raw material composition and parts by weight are: 340 parts of Radix Acanthus Radix, 265 parts of Achyranthes bidentata, 310 parts of Pentaclaw, 320 parts of Diaodia, 260 parts of Cadida , 200 parts of Zijinniu, 300 parts of Dawanhua, 340 parts of black resin, 450 parts of dried rehmannia, 225 parts of Geli, 350 parts of milk ginseng, 75 parts of astragalus, 100 parts of cornus, 75 parts of yam, 60 parts Cuscuta seed, 80 parts of Chuanxiong, 40 parts of licorice, 45 parts of Ganoderma lucidum, 50 parts of Epimedium, 55 parts of tangerine peel, 38 parts of Cistanche, 72 parts of Polygonum multiflorum, 55 parts of Cornus officinalis, 85 parts of woody fragrance.

[0065] The preparation method is as follows:

[0066] (1) Prepare materials, prepare each component according to the formula;

[0067] (2) Clean the prepared raw materials with flowing tap water respectively, dry them, and set them aside;

[00...

Embodiment 3

[0074] Embodiment 3: A kind of medicament for treating myasthenia gravis, raw material composition and parts by weight are: 370 parts of Radix Acanthus Radix, 300 parts of Achyranthes bidentata, 360 parts of Pentaclaw, 400 parts of Diaodia, 340 parts of Cadida , 250 parts of Zijinniu, 400 parts of Dawanhua, 420 parts of black sesame, 550 parts of dried rehmannia glutinosa, 300 parts of Geli, 400 parts of milk ginseng, 100 parts of astragalus, 120 parts of cornus, 90 parts of yam, 70 parts of Cuscuta, 120 parts of Chuanxiong, 50 parts of licorice, 55 parts of Ganoderma lucidum, 60 parts of Epimedium, 60 parts of tangerine peel, 48 parts of Cistanche, 80 parts of Polygonum multiflorum, 70 parts of Cornus officinalis, 110 parts of woody fragrance.

[0075]The preparation method is as follows:

[0076] (1) Prepare materials, prepare each component according to the formula;

[0077] (2) Clean the prepared raw materials with flowing tap water respectively, dry them, and set them as...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug for treating myasthenia gravis and a preparation method thereof. The drug comprises the following raw materials: girald acanthopanax bark, twotooth achyranthes root, humulus scandens, Chinese magnoliavine fruit, Chinese artichoke, japanese ardisia stem and leaf, ivy glorybind rhizome, black sesame, dried rehmannia root, oriental grape, rigescent hawksbeard root, astragalus, cornus pulp, Chinese yam, dodder, rhizoma chuanxiong, liquorice, glossy ganoderma, epimedium herb, dried orange peel, cistanche, tuber fleeceflower root, cornus and costus root. The drug disclosed by the invention is mainly based on spleen and kidney treatment to treat myasthenia gravis by using traditional Chinese medicines through a method of tonifying the kidneys and spleen, so that the side effects brought by western medicine immunity inhibitors can be avoided; and the drug is remarkable in treatment effect, and stable and lasting in curative effect.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a medicament for treating myasthenia gravis and a preparation method thereof. Background technique [0002] Myasthenia gravis is an autoimmune disease caused by conduction dysfunction at the neuromuscular junction. It is characterized by severe muscle weakness and muscle fatigue, which is exacerbated after exercise and becomes lighter and worse at night. In the early stage of the disease, eye muscles are most commonly involved, with drooping eyelids and limited eye movement, accompanied by diplopia and strabismus. As the disease progresses, if the facial muscles are involved, there may be weakness in closing eyes, difficulty in blowing air, and difficulty in chewing; if the throat muscles are involved, there may be choking of drinking water and difficulty in swallowing; if the neck muscles are involved, dyspnea and even respiratory failure may occur; Paraly...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8945A61K47/40A61K47/10A61P21/04
Inventor 王霞张绍坤
Owner 王霞
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com